| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-94011-0.02ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52678-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52675-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81114-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75907SS | |||
![ELISA: Human CGRP1 ELISA Kit (Colorimetric) [NBP2-75259] - Samples were spiked with high concentrations of Human CGRP1 and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.](http://images.novusbio.com/fullsize/nbp2-75259_human-cgrp1-elisa-kit-colorimetric-13220241681470.jpg "ELISA: Human CGRP1 ELISA Kit (Colorimetric) [NBP2-75259] - Samples were spiked with high concentrations of Human CGRP1 and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.")
![ELISA: Human CGRP1 ELISA Kit (Colorimetric) [NBP2-75259] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp2-75259_human-cgrp1-elisa-kit-colorimetric-43202490350.jpg)
![Western Blot: MeCP2 [p Ser421] Antibody [NBP2-29524] - Western blot of mouse whole brain showing specific immunolabeling of the ~55k truncated MeCP2 protein phosphorylated at Ser421. Immunolabeling is greatly reduced by preadsorption with the phospho-peptide used as antigen (peptide), but not by the corresponding dephospho-peptide (not shown).](http://images.novusbio.com/fullsize/MeCP2-[p-Ser421]-Antibody-Western-Blot-NBP2-29524-img0001.jpg "Western Blot: MeCP2 [p Ser421] Antibody [NBP2-29524] - Western blot of mouse whole brain showing specific immunolabeling of the ~55k truncated MeCP2 protein phosphorylated at Ser421. Immunolabeling is greatly reduced by preadsorption with the phospho-peptide used as antigen (peptide), but not by the corresponding dephospho-peptide (not shown).")
![Western Blot: Retinoic Acid Receptor beta Antibody (336) [NB200-323] - Western blot of Rat hippocampal lysate showing specific immunolabeling of the ~ 48k RAR-B isotype.](http://images.novusbio.com/fullsize/Retinoic-Acid-Receptor-beta-Antibody-336-Western-Blot-NB200-323-img0004.jpg "Western Blot: Retinoic Acid Receptor beta Antibody (336) [NB200-323] - Western blot of Rat hippocampal lysate showing specific immunolabeling of the ~ 48k RAR-B isotype.")
![Western Blot: SUR1 Antibody [NBP1-00138] - (0.5ug/ml) staining of Human Cer(35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/SUR1-Antibody-Western-Blot-NBP1-00138-img0002.jpg "Western Blot: SUR1 Antibody [NBP1-00138] - (0.5ug/ml) staining of Human Cer(35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.")
![Western Blot: Nogo Receptor/NgR Antibody [NB100-1536] - (0.3ug/ml) staining of Human Brain lysate (35ug protein in RIPA buffer) with (B) and without (A) blocking with the immunising peptide. Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/Nogo-Receptor-NgR-Antibody-Western-Blot-NB100-1536-img0002.jpg "Western Blot: Nogo Receptor/NgR Antibody [NB100-1536] - (0.3ug/ml) staining of Human Brain lysate (35ug protein in RIPA buffer) with (B) and without (A) blocking with the immunising peptide. Primary incubation was 1 hour. Detected by chemiluminescence.")
![Western Blot: OBCAM/OPCML Antibody [NBP2-94011] - Analysis of extracts of various cell lines, using OBCAM/OPCML at 1:1000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit .Exposure time: 10s.](http://images.novusbio.com/fullsize/OBCAM-OPCML-Antibody-Western-Blot-NBP2-94011-img0001.jpg "Western Blot: OBCAM/OPCML Antibody [NBP2-94011] - Analysis of extracts of various cell lines, using OBCAM/OPCML at 1:1000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit .Exposure time: 10s.")
![Western Blot: GABA-A R beta 2 Antibody (6G9O8) [NBP3-15403] - Analysis of extracts of various cell lines, using GABA-A R beta 2 (GABRB2) Rabbit mAb (NBP3-15403) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.](http://images.novusbio.com/fullsize/GABA-A-R-beta-2-Antibody-6G9O8-Western-Blot-NBP3-15403-img0001.jpg "Western Blot: GABA-A R beta 2 Antibody (6G9O8) [NBP3-15403] - Analysis of extracts of various cell lines, using GABA-A R beta 2 (GABRB2) Rabbit mAb (NBP3-15403) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.")
![Flow Cytometry: CD40 Ligand/TNFSF5 Antibody (hu5c8 (Ruplizumab)) - Chimeric [NBP2-52678] - Flow-cytometry using the anti-CD40L research biosimilar antibody Ruplizumab. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Ruplizimab (NBP2-52678, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-hu5c8-Ruplizumab-Chimeric-Flow-Cytometry-NBP2-52678-img0003.jpg "Flow Cytometry: CD40 Ligand/TNFSF5 Antibody (hu5c8 (Ruplizumab)) - Chimeric [NBP2-52678] - Flow-cytometry using the anti-CD40L research biosimilar antibody Ruplizumab. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Ruplizimab (NBP2-52678, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Immunocytochemistry/Immunofluorescence: CD40 Ligand/TNFSF5 Antibody (YMF323.6) [NBP2-81114] - Immunofluorescence staining of fixed human peripheral blood monocytes (PBMs) with [NBP2-81114]. Immunofluorescence analysis of paraformaldehyde fixed human PBMs on Shi-fix coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of YMF323.6 [NBP2-81114] at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81114, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-YMF323-6-Immunocytochemistry-Immunofluorescence-NBP2-81114-img0001.jpg "Immunocytochemistry/Immunofluorescence: CD40 Ligand/TNFSF5 Antibody (YMF323.6) [NBP2-81114] - Immunofluorescence staining of fixed human peripheral blood monocytes (PBMs) with [NBP2-81114]. Immunofluorescence analysis of paraformaldehyde fixed human PBMs on Shi-fix coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of YMF323.6 [NBP2-81114] at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81114, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.")
![Western Blot: CD40 Ligand/TNFSF5 Antibody (hu5c8 (Ruplizumab)) [NBP2-75907] - Rat spleen (lane 1), rat muscle (lane 2), rat bladder (lane 3), human breast tumour (lane 4) and human thyroid tumour (lane 5) samples were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75907 at 1 ug/ml before being detected by a secondary antibody. The expected band size (29 kDa) is seen in the human-derived samples, as well as bands corresponding to dimers and other multimers.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-hu5c8-Ruplizumab-Western-Blot-NBP2-75907-img0001.jpg "Western Blot: CD40 Ligand/TNFSF5 Antibody (hu5c8 (Ruplizumab)) [NBP2-75907] - Rat spleen (lane 1), rat muscle (lane 2), rat bladder (lane 3), human breast tumour (lane 4) and human thyroid tumour (lane 5) samples were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75907 at 1 ug/ml before being detected by a secondary antibody. The expected band size (29 kDa) is seen in the human-derived samples, as well as bands corresponding to dimers and other multimers.")